Thus, the oligodendroglial C9C5+Shh-associated signal should undoubtedly be taken into consideration when analyzing brain disorders associated to Shh signaling including brain tumors, neurodevelopmental disorders and neurodegenerative diseases [2]. This evidence concerns the gene SHH and brain neoplasm.